Teriflunomide Tablet, Film Coated
Product Images NDC 68462-423

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 68462-423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

A Kaplan-Meier curve showing disability progression sustained for 12 weeks over time in weeks for placebo, 7 mg teriflunomide, and 14 mg teriflunomide groups. The y-axis represents the percentage of disability progression sustained, and the x-axis shows weeks up to 108. The placebo group shows higher sustained disability progression (27.3%) compared to the teriflunomide groups (21.7% for 7 mg and 20.2% for 14 mg). The number of patients at risk is listed below the graph for each time point.*

FDA Label Image

Figure2.jpg (Figure2)

A line graph showing disability progression sustained over 12 weeks (%) on the vertical axis and weeks on the horizontal axis, comparing placebo, 7 mg teriflunomide, and 14 mg teriflunomide groups. The graph includes a legend and a table of number at risk for each treatment group at various time points.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of teriflunomide, showing its molecular configuration including its trifluoromethyl-substituted phenyl ring and cyano and hydroxyl groups.*

FDA Label Image

14mg Bottle 30 (Bottle Label 14mg)

Teriflunomide Tablets 14 mg film-coated tablets packaging label by Glenmark Pharmaceuticals Inc., USA. Contains 30 tablets. The label includes dosage instructions, storage warnings, pharmacist guidance, manufacturer details, NDC 68462-424-30, and a barcode.*

FDA Label Image

7mg Bottle 30 (Bottle Label 7mg)

Teriflunomide Tablets 7 mg film-coated oral tablets in a carton label. The package contains 30 tablets and is labeled for prescription use only. The label displays dosage instructions, storage conditions, manufacturer Glenmark Pharmaceuticals Inc., USA, and a barcode.*

FDA Label Image

Glenmark-logo (Glenmark Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.